USPTO serial 88732568
STEMCELL TECHNOLOGIES
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLARK, ANDREW T
- Law office
- TMEG LAW OFFICE 107
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with STEMCELL TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lisa M. Melanson
Lisa M. Melanson MCCARTHY TÉTRAULT LLPC/O SUITE 2200, 745 THURLOW STREETVANCOUVER, BC, V6E0C5CanadaGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Growth media, tissue culture media, cryopreservation media, cytokines, small molecules for research applications, cells, antibodies, and reagents; cell separation reagents; tissue culture media, growth factors, small molecules, growth media, serum, nutritional supplements and cryopreservation media for the in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; kits comprising molecular tags and reagents for labelling antibodies; coatings of biological materials and cryopreservation media for the growth, expansion, differentiation or manipulation of cells, microorganisms, tissues, or organs; reagents and kits comprised of reagents; specialized liquid and semi-liquid media and support reagents and cryopreservation media for growth, cloning or experimental analysis of cells; all for scientific, research, laboratory, and non-medical diagnostic use | ACTIVE | — |
| 005 | Growth media, tissue culture media, cryopreservation media, cytokines, small molecules for research applications, cells, antibodies, and reagents; cell separation reagents; tissue culture media, growth factors, small molecules, growth media, serum, nutritional supplements and cryopreservation media for the in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; kits comprising molecular tags and reagents for labelling antibodies; coatings of biological materials and cryopreservation media for the growth, expansion, differentiation or manipulation of cells, microorganisms, tissues, or organs; reagents and kits comprised of reagents; specialized liquid and semi-liquid media and support reagents and cryopreservation media for growth, cloning or experimental analysis of cells; all for medical and medical clinical use | ACTIVE | — |
| 009 | Scientific instrument comprising hardware and recorded software for the automated separation and analysis of biological and non-biological materials; laboratory equipment, namely, cell separation equipment; downloadable computer software used for the collection, organization, analysis, integration and communication of scientific data; laboratory equipment, namely, laboratory glassware, culture dishes, wells, in the nature of plastic trays with depressions, pipettors, pumps, needles and syringes for laboratory use; bioreactors, namely, fermentation reactors for laboratory use | ACTIVE | — |
| 042 | Consultation, research and development services in the field of hematology, immunology, therapeutic research, and life science; scientific research services, namely, contract assays services and proficiency testing services in the field of hematology, immunology, therapeutic research, and life science; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing on-line non-downloadable computer software used for the collection, organization, analysis, integration and communication of scientific data | ACTIVE | — |
| 044 | Medical services, namely, medical diagnostic services, disease therapy services and transplant services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by STEMCELL Technologies Canada Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named STEMCELL TECHNOLOGIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 28, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 28, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 23, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 23, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 23, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 26, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 15, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 14, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 14, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 14, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 25, 2024 | ALIE | ASSIGNED TO LIE | — |
| Jul 22, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 30, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 30, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 30, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 8, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 17, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 17, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 17, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 12, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 29, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 29, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 29, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 29, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 29, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 29, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 21, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 1, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 29, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 31, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 30, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 13, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 13, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 13, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 21, 2019 | NWAP | NEW APPLICATION ENTERED | — |